A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer
Clinical trial NCT00887822 · COMPLETED
Trial details
- NCT number
- NCT00887822
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2011-05-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.